APA (7th ed.) Citation

Bissonnette, R., Fernández‐Peñas, P., Puig, L., Mendelsohn, A., Rozzo, S., & Menter, A. (2020). Incidence of cardiovascular events among tildrakizumab‐treated patients with moderate‐to‐severe plaque psoriasis: Pooled data from three large randomised clinical trials. Journal of the European Academy of Dermatology & Venereology, 34(1), e21. https://doi.org/10.1111/jdv.15866

Chicago Style (17th ed.) Citation

Bissonnette, R., P. Fernández‐Peñas, L. Puig, A.M Mendelsohn, S.J Rozzo, and A. Menter. "Incidence of Cardiovascular Events Among Tildrakizumab‐treated Patients with Moderate‐to‐severe Plaque Psoriasis: Pooled Data from Three Large Randomised Clinical Trials." Journal of the European Academy of Dermatology & Venereology 34, no. 1 (2020): e21. https://doi.org/10.1111/jdv.15866.

MLA (9th ed.) Citation

Bissonnette, R., et al. "Incidence of Cardiovascular Events Among Tildrakizumab‐treated Patients with Moderate‐to‐severe Plaque Psoriasis: Pooled Data from Three Large Randomised Clinical Trials." Journal of the European Academy of Dermatology & Venereology, vol. 34, no. 1, 2020, p. e21, https://doi.org/10.1111/jdv.15866.